14 employees
ImmunoBrain Checkpoint is a biopharmaceutical company.
2015
$5M
from 2 investors over 2 rounds
ImmunoBrain Checkpoint raised $5M on August 27, 2021
Investors: National Institutes of Health
ImmunoBrain Checkpoint raised $500K on April 1, 2020
Investors: The ALS Association